Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors.
Johnston AC, Alicea GM, Lee CC, Patel PV, Hanna EA, Vaz E, Forjaz A, Wan Z, Nair PR, Lim Y, Chen T, Du W, Kim D, Nichakawade TD, Rebecca VW, Bonifant CL, Fan R, Kiemen AL, Wu PH, Wirtz D. Johnston AC, et al. Among authors: alicea gm. bioRxiv [Preprint]. 2024 Mar 26:2023.12.13.571595. doi: 10.1101/2023.12.13.571595. bioRxiv. 2024. PMID: 38168186 Free PMC article. Preprint.
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Jagirdar K, Portuallo ME, Wei M, Wilhide M, Bravo Narula JA, Robertson BM, Alicea GM, Aguh C, Xiao M, Godok T, Fingerman D, Brown GS, Herlyn M, Elad VM, Guo X, Toska E, Zabransky DJ, Wubbenhorst B, Nathanson KL, Kwatra S, Goyal Y, Ji H, Liu Q, Rebecca VW. Jagirdar K, et al. Among authors: alicea gm. Oncogene. 2024 Feb;43(6):395-405. doi: 10.1038/s41388-023-02900-6. Epub 2023 Dec 8. Oncogene. 2024. PMID: 38066089 Free PMC article.
Disrupting cellular memory to overcome drug resistance.
Harmange G, Hueros RAR, Schaff DL, Emert B, Saint-Antoine M, Kim LC, Niu Z, Nellore S, Fane ME, Alicea GM, Weeraratna AT, Simon MC, Singh A, Shaffer SM. Harmange G, et al. Among authors: alicea gm. Nat Commun. 2023 Nov 6;14(1):7130. doi: 10.1038/s41467-023-41811-8. Nat Commun. 2023. PMID: 37932277 Free PMC article.
Progress in melanoma treatment: Patient's perspectives.
Alicea GM, Villanueva J, Webster MR, Rebecca VW. Alicea GM, et al. Pigment Cell Melanoma Res. 2023 Nov;36(6):594-601. doi: 10.1111/pcmr.13138. Epub 2023 Oct 11. Pigment Cell Melanoma Res. 2023. PMID: 37819777 Free PMC article.
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.
Goyal Y, Busch GT, Pillai M, Li J, Boe RH, Grody EI, Chelvanambi M, Dardani IP, Emert B, Bodkin N, Braun J, Fingerman D, Kaur A, Jain N, Ravindran PT, Mellis IA, Kiani K, Alicea GM, Fane ME, Ahmed SS, Li H, Chen Y, Chai C, Kaster J, Witt RG, Lazcano R, Ingram DR, Johnson SB, Wani K, Dunagin MC, Lazar AJ, Weeraratna AT, Wargo JA, Herlyn M, Raj A. Goyal Y, et al. Among authors: alicea gm. Nature. 2023 Aug;620(7974):651-659. doi: 10.1038/s41586-023-06342-8. Epub 2023 Jul 19. Nature. 2023. PMID: 37468627 Free PMC article.
Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.
Fane ME, Ecker BL, Kaur A, Marino GE, Alicea GM, Douglass SM, Chhabra Y, Webster MR, Marshall A, Colling R, Espinosa O, Coupe N, Maroo N, Campo L, Middleton MR, Corrie P, Xu X, Karakousis GC, Weeraratna AT. Fane ME, et al. Among authors: alicea gm. Clin Cancer Res. 2023 May 15;29(10):2012. doi: 10.1158/1078-0432.CCR-23-0871. Clin Cancer Res. 2023. PMID: 37183634 No abstract available.
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma.
Rebecca V, Jagirdar K, Portuallo M, Wei M, Wilhide M, Bravo J, Robertson B, Alicea G, Aguh C, Xiao M, Godok T, Fingerman D, Brown G, Herlyn M, Guo B, Toska E, Zabransky D, Wubbenhorst B, Nathanson K, Kwatra S, Goyal Y, Ji H, Liu Q. Rebecca V, et al. Among authors: alicea g. Res Sq [Preprint]. 2023 Apr 20:rs.3.rs-2817876. doi: 10.21203/rs.3.rs-2817876/v1. Res Sq. 2023. PMID: 37131684 Free PMC article. Updated. Preprint.
Diversity, equity, and inclusion in the melanoma research community.
Portuallo ME, Lu DY, Alicea GM, Bolling J, Lee R, McQuade J, Warner AB, Davies M, Weeraratna A, Villanueva J, Rebecca VW. Portuallo ME, et al. Among authors: alicea gm. Pigment Cell Melanoma Res. 2023 Sep;36(5):441-447. doi: 10.1111/pcmr.13087. Epub 2023 Apr 24. Pigment Cell Melanoma Res. 2023. PMID: 37093838 Free PMC article.
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
Rebecca VW, Xiao M, Kossenkov A, Godok T, Brown GS, Fingerman D, Alicea GM, Wei M, Ji H, Bravo J, Chen Y, Fane ME, Villanueva J, Nathanson K, Liu Q, Gopal YNV, Davies MA, Herlyn M. Rebecca VW, et al. Among authors: alicea gm. bioRxiv [Preprint]. 2023 Jan 21:2023.01.20.524923. doi: 10.1101/2023.01.20.524923. bioRxiv. 2023. PMID: 36711814 Free PMC article. Preprint.
30 results